600721 百花医药
已收盘 04-24 15:00:00
资讯
新帖
简况
百花医药(600721)2026年一季报简析:净利润同比下降67.94%,三费占比上升明显
证券之星 · 30分钟前
百花医药(600721)2026年一季报简析:净利润同比下降67.94%,三费占比上升明显
每周股票复盘:百花医药(600721)Q1净利降67.94%
证券之星 · 05:10
每周股票复盘:百花医药(600721)Q1净利降67.94%
百花医药(600721.SH)发布一季度业绩,归母净利润664万元,同比下降67.94%
智通财经 · 04-24 17:24
百花医药(600721.SH)发布一季度业绩,归母净利润664万元,同比下降67.94%
4月9日百花医药(600721)龙虎榜数据
证券之星 · 04-09
4月9日百花医药(600721)龙虎榜数据
百花医药(600721.SH):实控人将变更为金华市国资委 股票复牌
智通财经 · 04-07
百花医药(600721.SH):实控人将变更为金华市国资委 股票复牌
每周股票复盘:百花医药(600721)筹划控制权变更继续停牌
证券之星 · 04-05
每周股票复盘:百花医药(600721)筹划控制权变更继续停牌
百花医药(600721.SH):筹划控制权变更事项 继续停牌
智通财经 · 04-01
百花医药(600721.SH):筹划控制权变更事项 继续停牌
百花医药(600721.SH):筹划控制权变更事项 股票停牌
智通财经 · 03-30
百花医药(600721.SH):筹划控制权变更事项 股票停牌
百花医药因潜在控股权变更 3月31日起停牌
美股速递 · 03-30
百花医药因潜在控股权变更 3月31日起停牌
百花医药(600721)2月28日股东户数3.8万户,较上期增加49.73%
证券之星 · 03-28
百花医药(600721)2月28日股东户数3.8万户,较上期增加49.73%
百花医药(600721.SH)发布2025年度业绩,归母净利润4068.79万元,下降1.91%
智通财经 · 03-27
百花医药(600721.SH)发布2025年度业绩,归母净利润4068.79万元,下降1.91%
股市必读:百花医药(600721)今年截至3月3日累计跌幅已超30%
证券之星 · 03-04
股市必读:百花医药(600721)今年截至3月3日累计跌幅已超30%
股市必读:百花医药(600721)今年截至1月29日累计跌幅已超25%
证券之星 · 01-30
股市必读:百花医药(600721)今年截至1月29日累计跌幅已超25%
每周股票复盘:百花医药(600721)一周4次登龙虎榜
证券之星 · 01-18
每周股票复盘:百花医药(600721)一周4次登龙虎榜
每周股票复盘:百花医药(600721)三日跌幅偏离值累计达20%
证券之星 · 01-11
每周股票复盘:百花医药(600721)三日跌幅偏离值累计达20%
百花医药最新公告:公司生产经营正常不存在应披露而未披露的重大信息
证券之星 · 01-09
百花医药最新公告:公司生产经营正常不存在应披露而未披露的重大信息
1月9日百花医药(600721)龙虎榜数据
证券之星 · 01-09
1月9日百花医药(600721)龙虎榜数据
股市必读:百花医药(600721)1月7日收盘跌停
证券之星 · 01-08
股市必读:百花医药(600721)1月7日收盘跌停
1月7日百花医药(600721)龙虎榜数据
证券之星 · 01-07
1月7日百花医药(600721)龙虎榜数据
百花医药(600721.SH)实控人终止筹划控制权变更事项 1月7日起复牌
智通财经 · 01-06
百花医药(600721.SH)实控人终止筹划控制权变更事项 1月7日起复牌
加载更多
公司概况
公司名称:
新疆百花村医药集团股份有限公司
所属行业:
研究和试验发展
上市日期:
1996-06-26
主营业务:
新疆百花村医药集团股份有限公司的主营业务是新药早期发现与筛选、药物CMC开发、临床试验、注册申报、BE/PK生物样品分析及药学检测服务、临床SMO及数据服务、MAH服务、API及中间体技术服务。公司的主要产品是医药研发、临床试验、其他医药、租赁及物业服务。报告期内,新增发明专利申请17件,实用新型专利申请7件。
发行价格:
4.20
{"stockData":{"symbol":"600721","market":"SH","secType":"STK","nameCN":"百花医药","latestPrice":8.7,"timestamp":1777014001000,"preClose":8.65,"halted":0,"volume":8652300,"delay":0,"changeRate":0.0058,"floatShares":385000000,"shares":385000000,"eps":0.0692,"marketStatus":"已收盘","change":0.05,"latestTime":"04-24 15:00:00","open":8.65,"high":8.72,"low":8.61,"amount":74929800,"amplitude":0.0127,"askPrice":8.71,"askSize":1367,"bidPrice":8.7,"bidSize":1058,"shortable":0,"etf":0,"ttmEps":0.0692,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":5,"adr":0,"adjPreClose":8.65,"symbolType":"stock","openAndCloseTimeList":[[1776994200000,1777001400000],[1777006800000,1777014000000]],"highLimit":9.52,"lowLimit":7.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":384547635,"isCdr":false,"pbRate":4.17,"roa":"--","peRate":125.722543,"roe":"0.83%","epsLYR":0.1059,"committee":-0.127723,"marketValue":3346000000,"turnoverRate":0.0225,"status":0,"floatMarketCap":3346000000},"requestUrl":"/m/hq/s/600721","defaultTab":"news","newsList":[{"id":"2630807561","title":"百花医药(600721)2026年一季报简析:净利润同比下降67.94%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807561","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807561?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:08","pubTimestamp":1777154916,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期百花医药发布2026年一季报。截至本报告期末,公司营业总收入6718.29万元,同比下降30.68%,归母净利润664.27万元,同比下降67.94%。本报告期百花医药三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达41.47%。去年的净利率为10.48%,算上全部成本后,公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802182","title":"每周股票复盘:百花医药(600721)Q1净利降67.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802182","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630802182?lang=zh_cn&edition=full","pubTime":"2026-04-26 05:10","pubTimestamp":1777151428,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,百花医药报收于8.7元,较上周的8.92元下跌2.47%。本周,百花医药4月20日盘中最高价报9.0元。本周关注点股本股东变化:截至2026年3月31日股东户数达3.99万户,环比增5.21%业绩披露要点:2026年一季度归母净利润664.27万元,同比下降67.94%股本股东变化股东户数变动截至2026年3月31日,公司股东户数为3.99万户,较2月28日增加1977.0户,增幅5.21%。户均持股数量由上期的1.01万股减少至9631.0股,户均持股市值为9.8万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0216","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629148668","title":"百花医药(600721.SH)发布一季度业绩,归母净利润664万元,同比下降67.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629148668","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629148668?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:24","pubTimestamp":1777022640,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药(600721.SH)披露2026年第一季度报告,报告期公司实现营收6718万元,同比下降30.68%;归母净利润664万元,同比下降67.94%;扣非净利润545万元,同比下降72.83%。基本每股收益0.0173元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"百花医药(600721.SH)发布一季度业绩,归母净利润664万元,同比下降67.94%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626900290","title":"4月9日百花医药(600721)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2626900290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626900290?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:14","pubTimestamp":1775726043,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年4月9日公布的交易公开信息显示,百花医药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年4月9日收盘,百花医药报收于10.2元,下跌8.93%,换手率24.18%,成交量93.0万手,成交额9.85亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900027246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","600721","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930636","title":"百花医药(600721.SH):实控人将变更为金华市国资委 股票复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930636","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625930636?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:00","pubTimestamp":1775563233,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药 发布公告,2026年4月7日,公司控股股东、实际控制人米在齐先生、米恩华先生、杨小玲女士与金华聚新签署了《股份转让协议书》。本次权益变动后,金华聚新将持有公司7952.51万股股份,占公司股份总数的20.68%,米在齐先生、米恩华先生、杨小玲女士将不再持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"百花医药(600721.SH):实控人将变更为金华市国资委 股票复牌","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721","BK0216","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625114776","title":"每周股票复盘:百花医药(600721)筹划控制权变更继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2625114776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625114776?lang=zh_cn&edition=full","pubTime":"2026-04-05 04:26","pubTimestamp":1775334370,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘,百花医药报收于10.18元,较上周的10.0元上涨1.8%。本周,百花医药3月30日盘中最高价报10.24元。百花医药当前最新总市值39.15亿元,在医疗服务板块市值排名42/51,在两市A股市值排名3897/5193。本周关注点公司公告汇总:百花医药因筹划控制权变更事项,自2026年3月31日起停牌,并于4月2日起继续停牌不超过3个交易日。公司将根据进展情况履行信息披露义务,待事项确定后及时公告并申请复牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0102","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624495593","title":"百花医药(600721.SH):筹划控制权变更事项 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2624495593","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624495593?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:10","pubTimestamp":1775031001,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药(600721.SH)发布公告,公司于2026年3月30日收到公司控股股东、实际控制人米在齐先生、米恩华先生、杨小玲女士的通知,米在齐先生、米恩华先生、杨小玲女士正在筹划公司股份协议转让事宜,该事项可能导致公司控制权发生变更。公司股票已于2026年3月31日开市起停牌。截至公告披露日,上述事项仍处于筹划之中,公司控股股东、实际控制人正与相关方积极推进本次事项的各项工作,公司预计无法在2026年4月2日(星期四)开市起复牌。公司股票将于2026年4月2日(星期四)开市起继续停牌,预计继续停牌时间不超过3个交易日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"百花医药(600721.SH):筹划控制权变更事项 继续停牌","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721","BK0102","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623807390","title":"百花医药(600721.SH):筹划控制权变更事项 股票停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2623807390","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623807390?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:37","pubTimestamp":1774859858,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药(600721.SH)发布公告,公司于2026年3月30日收到公司控股股东、实际控制人米在齐先生、米恩华先生、杨小玲女士的通知,米在齐先生、米恩华先生、杨小玲女士正在筹划公司股份协议转让事宜,该事项可能导致公司控制权发生变更。公司股票将于2026年3月31日(星期二)开市起停牌,预计停牌时间不超过2个交易日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"百花医药(600721.SH):筹划控制权变更事项 股票停牌","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721","BK0216","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194280467","title":"百花医药因潜在控股权变更 3月31日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1194280467","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194280467?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:33","pubTimestamp":1774859590,"startTime":"0","endTime":"0","summary":"百花医药(600721)发布公告称,公司股票自3月31日起停牌,以待披露潜在控股权变更相关事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600721","BK0102","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622385473","title":"百花医药(600721)2月28日股东户数3.8万户,较上期增加49.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622385473","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622385473?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:03","pubTimestamp":1774688591,"startTime":"0","endTime":"0","summary":"证券之星消息,近日百花医药披露,截至2026年2月28日公司股东户数为3.8万户,较12月31日增加1.26万户,增幅为49.73%。户均持股数量由上期的1.52万股减少至1.01万股,户均持股市值为9.38万元。在医疗服务行业个股中,百花医药股东户数低于行业平均水平,截至2月28日,医疗服务行业平均股东户数为4.5万户。从股价来看,2025年12月31日至2026年2月28日,百花医药区间跌幅为24.35%,在此期间股东户数增加1.26万户,增幅为49.73%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0216","600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622842715","title":"百花医药(600721.SH)发布2025年度业绩,归母净利润4068.79万元,下降1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622842715","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622842715?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:37","pubTimestamp":1774604232,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药(600721.SH)发布2025年年度报告,该公司营业收入为3.88亿元,同比增长0.66%。归属于上市公司股东的净利润为4068.79万元,同比减少1.91%。归属于上市公司股东的扣除非经常性损益的净利润为3278.58万元,同比增长10.57%。基本每股收益为0.1059元。此外,拟向全体股东每股派发现金红利0.04元(含税)。报告期内,公司持续强化项目全周期管理,着力提升申报效率和获批率,共申报受理项目146项(上年同期为141项),获批品规111项,同比增长20.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420509.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616697373","title":"股市必读:百花医药(600721)今年截至3月3日累计跌幅已超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616697373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616697373?lang=zh_cn&edition=full","pubTime":"2026-03-04 02:28","pubTimestamp":1772562491,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘,百花医药报收于8.66元,下跌3.24%,换手率3.18%,成交量12.25万手,成交额1.08亿元。当日关注点来自交易信息汇总:百花医药股价已连续4日下跌,2026年累计跌幅达31.12%。交易信息汇总股价提醒3月3日百花医药收盘报8.66元,跌3.24%,当日成交1224.56万元。前10个交易日资金流向情况:主力资金累计净流出4452.13万元,股价累计下跌7.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400001360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0216","600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607030461","title":"股市必读:百花医药(600721)今年截至1月29日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607030461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607030461?lang=zh_cn&edition=full","pubTime":"2026-01-30 02:15","pubTimestamp":1769710514,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘,百花医药报收于9.19元,下跌2.44%,换手率4.73%,成交量18.18万手,成交额1.68亿元。交易信息汇总股价提醒1月29日百花医药收盘报9.19元,跌2.44%,当日成交1818.21万元。该股已连续3日下跌,2026年累计跌幅26.55%。前10个交易日主力资金累计净流出6703.17万元,期间股价累计下跌6.03%。资金流向1月29日主力资金净流出1000.63万元,占总成交额5.97%;游资资金净流出520.09万元,占总成交额3.1%;散户资金净流入1520.71万元,占总成交额9.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000001288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","600721","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604233989","title":"每周股票复盘:百花医药(600721)一周4次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2604233989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604233989?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:26","pubTimestamp":1768674368,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,百花医药报收于9.84元,较上周的9.59元上涨2.61%。本周,百花医药1月13日盘中最高价报10.45元。本周关注点交易信息汇总:百花医药近5个交易日第4次因换手率超20%登龙虎榜股本股东变化:无相关信息业绩披露要点:无相关信息机构调研要点:无相关信息公司公告汇总:无相关信息交易信息汇总沪深交易所2026年1月13日公布的交易公开信息显示,百花医药因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0102","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602538533","title":"每周股票复盘:百花医药(600721)三日跌幅偏离值累计达20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602538533","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602538533?lang=zh_cn&edition=full","pubTime":"2026-01-11 01:27","pubTimestamp":1768066028,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,百花医药报收于9.59元,较上周的12.24元下跌21.65%。来自公司公告汇总:公司股票于1月7日至9日连续三日收盘价跌幅偏离值累计达20%,构成异常波动。交易信息汇总龙虎榜上榜沪深交易所2026年1月9日公布的交易公开信息显示,百花医药因非ST、*ST和S证券连续三个交易日内收盘价格跌幅偏离值累计达到20%的证券登上龙虎榜。此前筹划的控制权变更事项已终止,股票自2026年1月7日起复牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0102","600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602324544","title":"百花医药最新公告:公司生产经营正常不存在应披露而未披露的重大信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2602324544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602324544?lang=zh_cn&edition=full","pubTime":"2026-01-09 18:10","pubTimestamp":1767953401,"startTime":"0","endTime":"0","summary":"百花医药(600721.SH)公告称,公司股票在连续三个交易日内日收盘价格跌幅偏离值累计达到20%,属于股票交易异常波动。经自查,公司生产经营活动正常,市场环境或行业政策没有发生重大调整,内部生产经营秩序正常。此外,公司控股股东、实际控制人筹划控制权变更事项已终止,除已披露信息外,不存在应披露而未披露的重大信息。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900030045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0216","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602329715","title":"1月9日百花医药(600721)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2602329715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602329715?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:35","pubTimestamp":1767951316,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月9日公布的交易公开信息显示,百花医药因非ST、*ST和S证券连续三个交易日内收盘价格跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年1月9日收盘,百花医药报收于9.59元,下跌3.33%,换手率24.87%,成交量95.65万手,成交额9.1亿元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900028721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0102","600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601800594","title":"股市必读:百花医药(600721)1月7日收盘跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800594","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800594?lang=zh_cn&edition=full","pubTime":"2026-01-08 01:13","pubTimestamp":1767805989,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘,百花医药报收于11.02元,下跌9.97%,跌停,换手率0.86%,成交量3.3万手,成交额3636.38万元。来自公司公告汇总:百花医药终止筹划控制权变更事项,公司股票自2026年1月7日开市起复牌。交易信息汇总股价提醒1月7日百花医药收盘报11.02元,跌停,当日成交329.98万元。龙虎榜上榜沪深交易所2026年1月7日公布的交易公开信息显示,百花医药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800000640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0102","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601876026","title":"1月7日百花医药(600721)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601876026?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:38","pubTimestamp":1767778711,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月7日公布的交易公开信息显示,百花医药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月7日收盘,百花医药报收于11.02元,下跌9.97%,跌停,换手率0.86%,成交量3.3万手,成交额3636.38万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700027457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0216","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601321860","title":"百花医药(600721.SH)实控人终止筹划控制权变更事项 1月7日起复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2601321860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601321860?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:49","pubTimestamp":1767689353,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药(600721.SH)公告,公司控股股东、实际控制人米在齐先生、米恩华先生、杨小玲女士终止筹划控制权变更事项。公司股票将于2026年1月7日(星期三)开市起复牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK0102","600721"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777156677077,"stockEarnings":[{"period":"1week","weight":-0.0247},{"period":"1month","weight":-0.0928},{"period":"3month","weight":-0.1104},{"period":"6month","weight":-0.0502},{"period":"1year","weight":0.2411},{"period":"ytd","weight":-0.2892}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0377},{"period":"3month","weight":-0.0136},{"period":"6month","weight":0.0328},{"period":"1year","weight":0.2374},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"新疆百花村医药集团股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"39928人(较上一季度增加5.21%)","perCapita":"9631股","listingDate":"1996-06-26","address":"新疆维吾尔自治区五家渠市东工业园区纬六西街699号研发办公楼3号","registeredCapital":"38454万元","survey":" 新疆百花村医药集团股份有限公司的主营业务是新药早期发现与筛选、药物CMC开发、临床试验、注册申报、BE/PK生物样品分析及药学检测服务、临床SMO及数据服务、MAH服务、API及中间体技术服务。公司的主要产品是医药研发、临床试验、其他医药、租赁及物业服务。报告期内,新增发明专利申请17件,实用新型专利申请7件。","listedPrice":4.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百花医药(600721)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百花医药(600721)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百花医药,600721,百花医药股票,百花医药股票老虎,百花医药股票老虎国际,百花医药行情,百花医药股票行情,百花医药股价,百花医药股市,百花医药股票价格,百花医药股票交易,百花医药股票购买,百花医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百花医药(600721)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百花医药(600721)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}